Anesthetic implications of the new anticoagulant and antiplatelet drugs.
In this review, we discuss the anesthetic implications of the new anticoagulant and antiplatelet drugs, focusing our discussion mainly on neuroaxial/regional anesthesia and central catheter placement issues. We offer practical recommendations for their use.
Vitin
Alexander A
AA
Department of Anesthesiology, University of Washington, Campus PO Box 356540, 1959 NE Pacific Street, Seattle, WA 98195-6540, USA.
Dembo
Gregory
G
Vater
Youri
Y
Martay
Kenneth
K
Azamfirei
Leonard
L
Ezri
Tiberiu
T
D000758:Anesthesia; D000818:Animals; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D000990:Antithrombin III / Q000502:physiology; D065427:Factor Xa Inhibitors; D005340:Fibrinogen / Q000037:antagonists & inhibitors; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D013917:Thrombin / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D010975:Platelet Aggregation Inhibitors; D000990:Antithrombin III; D005340:Fibrinogen; D006493:Heparin; D013917:Thrombin